Treatment of chloroquine-resistant Plasmodium falciparum infections in Vietnam.
D002738:Chloroquine / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008887:Military Medicine; D011739:Pyrimethamine / Q000627:therapeutic use*; D011796:Quinacrine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use*; D013411:Sulfadiazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014744:Vietnam
D013449:Sulfonamides; D013411:Sulfadiazine; D002738:Chloroquine; D003622:Dapsone; D011803:Quinine; D011796:Quinacrine; D011739:Pyrimethamine